Literature DB >> 10453406

Future aspects of BMIPP.

N Tamaki1, K Morita, E Tsukamoto, Y Kawai.   

Abstract

Iodinated fatty acid compounds have an important role in early detection of myocardial abnormalities and provide insights into pathological states in the heart. Among them, 15-(p-iodophenyl)-3R,S-methyl pentadecanoic acid (BMIPP) has been most widely used providing excellent images of the left ventricular myocardium due to high myocardial uptake and long retention. The previous chapters have focused on the basic characters and clinical applications of this compound. However, the precise mechanisms of myocardial kinetics should be further investigated under various conditions. Most of the studies showed reduced BMIPP uptake relative to perfusion in a variety of myocardial disorders, whereas an increase in BMIPP uptake relative to perfusion is often reported. The potential mechanisms of such conflicting results are discussed, but basic studies should be performed to clarify such results in detail. There are a number of clinical values of this compound. Since alteration of fatty acid is observed in the repetitive ischemia, BMIPP can be used for detecting severe ischemic episodes. The concept of 'ischemic memory' imaging can be applied for patients with unstable or vasospastic angina at rest and for those with acute myocardial infarction with successful revascularization to identify the risk area. The discordant decrease in BMIPP uptake relative to perfusion is often seen in ischemic but viable myocardium, and therefore, the combined imaging of BMIPP and perfusion can be used for assessment of tissue viability. Furthermore, abnormal BMIPP uptake is most often observed in hypertrophic cardiomyopathy, and thus, this compound can be used for an early detection and differential diagnosis of the cardiomyopathy. Although BMIPP imaging seems to be quite promising in many fields, the number of patient data remain limited. In this respect, a multicenter study with a vast majority of patients is warranted to confirm these important values of BMIPP. In addition, this attractive tracer should be available all over the world to confirm its clinical value in the near future.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10453406     DOI: 10.1023/a:1006109022417

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN: 0167-9899


  62 in total

1.  Influence of blood substrate levels on myocardial kinetics of iodine-123-BMIPP.

Authors:  C Kurata; Y Wakabayashi; S Shouda; T Mikami; Y Takei; K Tawarahara; T Sugiyama; T Nakano; S Fujisawa; A Andoh
Journal:  J Nucl Med       Date:  1997-07       Impact factor: 10.057

2.  Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R,S)methylpentadecanoic acid (BMIPP), in relation to ATP concentration.

Authors:  Y Fujibayashi; Y Yonekura; Y Takemura; K Wada; K Matsumoto; N Tamaki; K Yamamoto; J Konishi; A Yokoyama
Journal:  J Nucl Med       Date:  1990-11       Impact factor: 10.057

3.  Detection of impaired fatty acid metabolism in right ventricular hypertrophy: assessment by I-123 beta-methyl iodophenyl pentadecanoic acid (BMIPP) myocardial single-photon emission computed tomography.

Authors:  Y Kim; H Goto; K Kobayashi; Y Sawada; Y Miyake; G Fujiwara; H Chiba; T Okada; T Nishimura
Journal:  Ann Nucl Med       Date:  1997-08       Impact factor: 2.668

4.  Assessment of improvement of myocardial fatty acid uptake and function after revascularization using iodine-123-BMIPP.

Authors:  J Taki; K Nakajima; I Matsunari; H Bunko; S Takata; M Kawasuji; N Tonami
Journal:  J Nucl Med       Date:  1997-10       Impact factor: 10.057

Review 5.  Recent advances in nuclear cardiology in the study of coronary artery disease.

Authors:  N Tamaki; E Tadamura; T Kudoh; N Hattori; M Inubushi; J Konishi
Journal:  Ann Nucl Med       Date:  1997-05       Impact factor: 2.668

6.  Fatty acid analogue accumulation: a marker of myocyte viability in ischemic-reperfused myocardium.

Authors:  D D Miller; J B Gill; E Livni; D R Elmaleh; T Aretz; C A Boucher; H W Strauss
Journal:  Circ Res       Date:  1988-10       Impact factor: 17.367

7.  Quantification of area at risk in acute myocardial infarction by tomographic imaging.

Authors:  Y Furutani; T Shiigi; Y Nakamura; H Nakamura; M Harada; T Yamamoto; T Wakeyama; M Nakatsuka; H Ogawa; M Matsuzaki
Journal:  J Nucl Med       Date:  1997-12       Impact factor: 10.057

8.  Regional myocardial free fatty acid extraction in normal and ischemic myocardium.

Authors:  K Vyska; H J Machulla; W Stremmel; D Fassbender; W H Knapp; G Notohamiprodjo; U Gleichmann; H Meyer; E J Knust; R Körfer
Journal:  Circulation       Date:  1988-11       Impact factor: 29.690

9.  Myocardial emission computed tomography with iodine-123-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy.

Authors:  C Kurata; K Tawarahara; T Taguchi; S Aoshima; A Kobayashi; N Yamazaki; H Kawai; M Kaneko
Journal:  J Nucl Med       Date:  1992-01       Impact factor: 10.057

10.  Heterogeneous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy.

Authors:  Y Takeishi; J Chiba; S Abe; I Tonooka; A Komatani; H Tomoike
Journal:  Eur J Nucl Med       Date:  1992
View more
  1 in total

1.  Using magnetic resonance imaging to characterize recent myocardial injury: utility in acute coronary syndrome and other clinical scenarios.

Authors:  Andrew E Arai
Journal:  Circulation       Date:  2008-08-19       Impact factor: 29.690

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.